⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
prnewswire.com
NVS
BIIB
SNY
MRK
BMY
JNJ
TEVA
VTRS
AMGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novartis AG (NVS) And Encourages Shareholders to Reach Out
accessnewswire.com
NVS
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX
Pharmaceutical Drug Delivery Market Forecasts Growth from $2.15T (2026) to $2.92T by 2031, Profiling J&J, Pfizer, Roche, BD & Novartis
globenewswire.com
JNJ
PFE
BDX
NVS
Lupus Nephritis Pipeline 2026: Targeted Therapies and Clinical Innovation Drive New Treatment and Market Opportunities Through the Forecast Period
globenewswire.com
NVS
Oncology Clinical Trials Market Set for Strong Growth Through 2035, Fueled by Precision Medicine, Immunotherapy and Decentralized Trial Innovation
globenewswire.com
AZN
MRK
NVS
LRCX
NVDA
GOOG
MSFT
AMGN
BMY
JNJ
PFE
LLY
ABBV
IQV
ICLR
LH
TMO
Bronstein, Gewirtz & Grossman, LLC Encourages Novartis AG (NVS) Stockholders to Inquire about Securities Investigation
accessnewswire.com
NVS
Hearing Loss Disease Treatment Market Advances as AI-Powered Hearing Aids Expand Patient Access Globally
globenewswire.com
PFE
NVS
GSK